Provider of R&D and associated tax claims services

  • Price: Offer Invited
Seller Ref:154927
For Sale

Provider of R&D and associated tax claims services

Seller Ref:154927
  • Price: Offer Invited

Overview

Seller Ref: 154927

Description

Project Fluorite expertly works with clients of all sizes throughout the UK to manage their R&D and capital allowance tax reclaim requirements, delivering an end-to-end service.

Long-standing relationships with accountants throughout the UK facilitate a steady stream of prospective clients.

The highly experienced technical personnel ensure that all claimable processes and assets are included in HMRC submissions, taking time to understand each client’s operations through ongoing contact and site visits.

Our clients are now offering the company for sale to facilitate retirement plans and lifestyle changes. Offers invited.

Key Highlights

– Services are sector-agnostic, enabling the business to operate within industries such as manufacturing, engineering, IT and automotive, amongst others.

– Director wishes to remain operational, post-sale, and can take on many responsibilities currently carried out by the exiting shareholders.

– Two candidates available to support the remaining shareholding Director.

– Operates from shareholder-owned premises, which are leased to the company; however, the business could be relocated.

– Current premises in Northern England present considerable scope for development to expand the business’s capabilities.

– Primed to take advantage of growing spend on R&D processes across the UK.

Financial Highlights

– Generated a YE23 turnover of £1.5m.

– Turnover is projected to increase to £2.1m in YE24, with an adjusted EBITDA of £386k anticipated.

– Approximately 97% of the clients are retained on long-lasting contracts.

– Circa 76% of revenue is derived from existing clients.

– Pipeline of circa 500 clients who are actively discussing their R&D activities.

– Generally, 40 cases are at the assessment stage and a further 20–30 claims are finalised each month.

Financial Commentary

Due to the nature and timing of R&D tax credit claims, the company experienced the effects of the pandemic after the event; this is demonstrated in the downturn from YE21 onwards. However, our clients anticipate that the YE24 figures will begin to show an uplift.

Is this business relocatable:
Yes
Is stock included:
NA

Listed By:

If this business isn't quite right for you, click 'Show Similar Results' for others you may be interested in. If this is for you, enter your details below to enquire today, we'll show you more suggestions once you've sent your enquiry to this seller.

Show Similar Results

Schedule a Tour

Your information

Find out more about this business opportunity

Your Personal Details * Required Field

Would you like a free no-obligation discussion with a qualified finance provider who could help you to buy this business?
You must agree before submitting.

Similar Listings

Find out more about this business opportunity

Compare listings

Compare
Send Enquiry